GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
GoodRx Holdings Inc. (NASDAQ: GDRX) will report its fourth quarter and full year 2022 financial results on February 28, 2023, after U.S. markets close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.
Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005919/en/
Investor Contact
ir@goodrx.com
Press Contact
lcasparis@goodrx.com
Source: